Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using tDCS (mild brain stimulation) to reduce vaping

Official title: Using Transcranial Direct Current Stimulation (tDCS) for Vaping Reduction in Daily E-cigarette Users: a Pilot Study

Run by Centre for Addiction and Mental Health · NCT06885606 · Data updated 2026-11-12

This project will try daily transcranial direct current stimulation (tDCS) to reduce cravings and vaping in adults who use nicotine e-cigarettes every day and are not planning to quit.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorCentre for Addiction and Mental Health
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedApril 2026
Study endsMay 2026
Registry record updatedMarch 19, 2026
Trial IDNCT06885606 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–65 who vape nicotine daily for at least six months, are not planning to quit in the next 30 days, can provide consent, and can attend daily clinic visits for two weeks.

Probably not a fit

People with other substance use disorders, current cigarette smokers or nicotine-replacement users, unstable psychiatric illness, a history of seizures, or those seeking immediate quit treatment may not receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–65 who have used nicotine e-cigarettes daily for at least six months and are not planning to quit will be enrolled at the Centre for Addiction and Mental Health in Toronto. Participants will receive either active tDCS or sham (placebo) tDCS and will attend daily stimulation sessions Monday through Friday for two consecutive weeks. The study will measure changes in vaping craving and behavior around the stimulation period. People with other substance use disorders, current tobacco or nicotine-replacement use, unstable psychiatric conditions, recent significant head trauma, or seizure history are excluded.

Why it matters

Potential benefit: If successful, this approach could reduce e-cigarette cravings and help some people cut down or stop vaping using a brief, low-cost noninvasive treatment.

How similar studies have gone: Prior tDCS studies have shown mixed but sometimes promising reductions in craving for nicotine and other substances, though specific evidence for vaping is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The participant must meet all of the inclusion criteria to be eligible for this research study:

  1. Be able to provide informed written consent
  2. Stated willingness to comply with all study procedures
  3. Age 18 - 65 years
  4. Is a daily regular use of nicotine-containing e-cigarette for at least the past 6 months
  5. Is willing to attend daily appointments for tDCS for two consecutive weeks (Monday through Friday)
  6. Is not interested in or planning to quit vaping in the next 30 days.

Exclusion Criteria:

* An individual who meets any of the following criteria will be excluded from participation in this research study:

  1. Substance use disorder (other than nicotine dependence) (M.I.N.I. SCID) (confirmed with urine drug screen)
  2. Current regular use of tobacco cigarettes, nicotine replacement therapy or other medications for smoking cessation
  3. Unstable psychiatric condition
  4. Recent clinically significant head trauma\*
  5. History of seizures and/or epilepsy\*
  6. Pacemakers or implanted electrical devices such as cochlear implants\*
  7. Metal embedded in the skull\*
  8. Skin lesions, open wounds, bruising, or similar injuries on the scalp\*

Where it's running

  • Centre for Addiction and Mental Health
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.